The Latest Cardiac and Vascular News
REDWOOD CITY, Calif., July 12, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has entered into a securities purchase agreement with certain institutional investors providing for the purchase and sale of 2,166,180 shares of common stock […]
EDEN PRAIRIE, Minn., July 12, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS), today announces it has entered into the German market by expanding a relationship with HSC-Medical, GmbH, a business solutions resource based in Germany. HSC-Medical will serve as a fulfillment house and logistical support for CHF Solutions, while the […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its second quarter 2018 financial results on Wednesday, August 1, 2018. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Wednesday, […]
July 11, 2018 11:45 AM Eastern Daylight Time PARIS–(BUSINESS WIRE)–Regulatory News: STENTYS (Paris:STNT) (FR0010949404 — STNT), a French group specialized in medical technologies for interventional cardiology, today reports its consolidated revenues and cash position at June 30, 2018. Christophe Lottin, Chief Executive Officer of STENTYS, comments: “The second quarter of 2018 notably […]
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today welcomed the publication of the iDissection Classification trial results in the current issue of Journal of Invasive Cardiology. Post-percutaneous transluminal angioplasty (“PTA”) dissections are often overlooked, underdiagnosed and left untreated. These dissections can compromise […]
NEW YORK–(BUSINESS WIRE)–PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that it has named Shaun M. O’Neil to serve as its first Chief Commercial Officer. Mr. O’Neil will oversee all aspects of the domestic and international commercialization of PAVmed’s products […]
PASADENA, Calif.–(BUSINESS WIRE)–Geneva Health Solutions (GHS), the leading cloud-based technology platform and service for managing data from implantable cardiac devices, announced it has hit a critical milestone for the number of practices using the GHS remote monitoring service and platform. In addition, the company secured a strategic investment and continues to […]
IRVINE, Calif., July 11, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced that it has initiated an analysis of its bioprosthetic heart valve in order to determine […]
Santa Monica, CA, July 11, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the research poster entitled “Unipolar Intracardiac Signal Morphology as a […]
BOLOGNA, Italy, July 11, 2018 /PRNewswire/ — ANGIODROID Srl, an Italian manufacturer of medical technologies, announces the CE mark for ANGIOPULSE, its first intra-aortic balloon pump (IABP) device. The new ANGIOPULSE IABP incorporates a new system for IABP management based on pressure regulation. Extremely sophisticated, ANGIOPULSE builds on the Italian experience of Angiodroid Srl (angiodroid.com), […]
